The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma

被引:91
作者
Koukourakis, M
Hlouverakis, G
Kosma, L
Skarlatos, J
Damilakis, J
Giatromanolaki, A
Yannakakis, D
机构
[1] UNIV HOSP IRAKLION, DEPT BIOSTAT, GR-71110 IRAKLION, GREECE
[2] ST SAVAS HOSP, HELLENIC CANC INST, DEPT RADIOTHERAPY ONCOL, ATHENS, GREECE
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1996年 / 34卷 / 02期
关键词
nonsmall cell lung cancer; radiotherapy; overall treatment time; normalized total dose;
D O I
10.1016/0360-3016(95)02102-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: We evaluated the impact of overall treatment time on the disease-free survival (DFS)and local control after radiotherapy for nonsmall cell Lung carcinoma. Methods and Materials: One hundred fifty-three cases considered as responders to radiotherapy were retrospectively analyzed, Patients with Karnofsky status < 70, pretreated with chemotherapy and with pleural or pericardial effusion, were excluded from the analysis, Radiation dose homogenization was done with calculation of the normalized total dose without (NTD) and with time correction (NTD-T) for alpha/beta = 10 Gy. Results: Kaplan-Meier curves for 2-year DFS showed that any analysis based on radiation dose can prove to be erroneous when the time factor is neglected, Although there was no difference between the 47-55 Gy and 56-64 Gy NTD groups, a log rank test revealed a strong difference (p < 0.0002) between NTD-T groups, No difference was observed for patients with mediastinal involvement, Logistic regression analysis showed a statistical association of dose on 2-year local progression-free probability for different time compartments, For those cases without mediastinal involvement, the daily dose lost because of treatment protraction beyond 20 days after the beginning of radiotherapy was estimated to 0.2 Gy/day, When all cases were considered together this was calculated to 0.45 Gy/day. Conclusion: Time factor shoud not be underestimated when evaluating the results of radiotherapy for nonsmall cell lung cancer, There is strong evidence that prolonged overall treatment time could be a major cause of the failure of radiotherapy to control the local disease.
引用
收藏
页码:315 / 322
页数:8
相关论文
共 25 条
[1]   N-2 (CLINICAL) NON-SMALL-CELL CARCINOMA OF THE LUNG - PROSPECTIVE TRIALS OF RADIATION-THERAPY WITH TOTAL DOSES 60 GY BY THE RADIATION-THERAPY-ONCOLOGY-GROUP [J].
COX, JD ;
AZARNIA, N ;
BYHARDT, RW ;
SHIN, KH ;
EMAMI, B ;
PEREZ, CA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (01) :7-12
[2]   LACK OF APPARENT DIFFERENCE IN OUTCOME BETWEEN CLINICALLY STAGED-IIIA AND STAGE-IIIB NON-SMALL-CELL LUNG-CANCER TREATED WITH RADIATION-THERAPY [J].
CURRAN, WJ ;
STAFFORD, PM .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (03) :409-415
[3]   PHASE-I/II STUDY OF TREATMENT OF LOCALLY ADVANCED (T3T4) NON-OAT CELL LUNG-CANCER WITH HIGH-DOSE RADIOTHERAPY (RAPID FRACTIONATION) - RADIATION-THERAPY ONCOLOGY GROUP-STUDY [J].
EMAMI, B ;
PEREZ, CA ;
HERSKOVICH, A ;
HEDERMAN, MA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (04) :1021-1025
[4]  
EMAMI B, 1987, PRINCIPLES PRACTICE, P650
[5]   INTERPRETING CANCER SURVIVAL RATES [J].
ENSTROM, JE ;
AUSTIN, DF .
SCIENCE, 1977, 195 (4281) :847-851
[6]   DETERMINATION OF TIME-DOSE RELATIONSHIPS FROM CLINICAL DATA [J].
FISCHER, JJ ;
FISCHER, DB .
BRITISH JOURNAL OF RADIOLOGY, 1971, 44 (526) :785-&
[7]   TREATMENT ACCELERATION IN RADIOTHERAPY - THE RELATIVE-TIME FACTORS AND DOSE-RESPONSE SLOPES FOR TUMORS AND NORMAL-TISSUES [J].
HENDRY, JH .
RADIOTHERAPY AND ONCOLOGY, 1992, 25 (04) :308-312
[8]  
HERMANE KP, 1988, TNM CLASSIFICATION M
[9]   THORACIC RADIOTHERAPY DOES NOT PROLONG SURVIVAL IN PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE NON-SMALL-CELL LUNG-CANCER [J].
JOHNSON, DH ;
EINHORN, LH ;
BARTOLUCCI, A ;
BIRCH, R ;
OMURA, G ;
PEREZ, CA ;
GRECO, FA .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (01) :33-38
[10]   RADIOTHERAPY ALONE FOR NONSMALL CELL LUNG-CARCINOMA - 5-YEAR DISEASE-FREE SURVIVAL AND PATTERNS OF FAILURE [J].
KOUKOURAKIS, M ;
SKARLATOS, J ;
KOSMA, L ;
GIATROMANOLAKI, A ;
YANNAKAKIS, D .
ACTA ONCOLOGICA, 1995, 34 (04) :525-530